'''Itrocinonide''' (developmental code name '''D5159''') is a [[synthetic compound|synthetic]] [[glucocorticoid]] [[corticosteroid]] which was never marketed.<ref name="BodorBuchwald2012">{{cite book|author1=Nicholas Bodor|author2=Peter Buchwald|title=Retrometabolic Drug Design and Targeting|url=https://books.google.com/books?id=Hjxe9jTGUfQC&pg=PT193|date=29 August 2012|publisher=John Wiley & Sons|isbn=978-1-118-40776-9|pages=193–}}</ref><ref name="Schleimer2016">{{cite book|author=Robert P. Schleimer|title=Inhaled Steroids in Asthma: Optimizing Effects in the Airways|url=https://books.google.com/books?id=ltjKBQAAQBAJ&pg=PA526|date=19 April 2016|publisher=CRC Press|isbn=978-0-203-90853-2|pages=526–}}</ref><ref name="HanselBarnes2001">{{cite book|author1=Trevor T. Hansel|author2=Peter J. Barnes|title=New Drugs for Asthma, Allergy and COPD|url=https://books.google.com/books?id=IFDp2Jq27PgC&pg=PA95|date=1 January 2001|publisher=Karger Medical and Scientific Publishers|isbn=978-3-8055-6862-3|pages=95–}}</ref>
